Tissue DonorsBlood DonorsLiving DonorsG1 PhaseS PhaseLeechesCell CycleMimosineCyclin-Dependent Kinase Inhibitor p21Cell DivisionCell Line, TumorTumor Cells, CulturedTissue and Organ ProcurementCyclin-Dependent Kinase Inhibitor p27G1 Phase Cell Cycle CheckpointsCell LineLeukemia P388CyclinsTransplantation, HomologousCell ProliferationGraft SurvivalApoptosisCell SurvivalCell Cycle ProteinsMultiple MyelomaLiver TransplantationDrug ResistanceKidney TransplantationTime FactorsCells, CulturedMolecular Sequence DataCyclin-Dependent Kinase 2Tissue and Organ HarvestingHistocompatibility TestingLeukemia, ExperimentalCyclin-Dependent KinasesFlow CytometryBone Marrow TransplantationTransfectionBrain DeathGraft vs Host DiseasePhosphorylationMutationBase SequenceGraft RejectionCyclin D1Retinoblastoma ProteinProto-Oncogene Proteins c-mycGene Expression Regulation, NeoplasticTumor Suppressor Protein p53CadaverCell DifferentiationBlotting, WesternCyclin ERNA, MessengerCDC2-CDC28 KinasesInsemination, Artificial, HeterologousSignal TransductionAntineoplastic AgentsDose-Response Relationship, DrugDNAEnzyme InhibitorsHistocompatibilityRNA, Small InterferingDrug Resistance, NeoplasmProtein-Serine-Threonine KinasesInterneuronsAmino Acid SequenceDNA-Binding ProteinsPhenotypeGene Expression RegulationFibroblastsMice, Inbred BALB COocyte DonationHematopoietic Stem Cell TransplantationProtein BindingNeuronsDNA DamageMice, NudeTumor Suppressor ProteinsProto-Oncogene ProteinsNeoplasm ProteinsOrgan PreservationTranscription FactorsCell Transformation, NeoplasticInsulin-Like Growth Factor IDirected Tissue DonationHeart TransplantationImmunohistochemistryCell NucleusTranscription, GeneticHLA AntigensTreatment OutcomeBlood BanksLeukocyte TransfusionBlood TransfusionRetrospective StudiesDown-RegulationTransplantation ConditioningTransplant Donor Site